• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甘氨酰酪氨酸对苯丙酮尿症患者饱腹感和饮食摄入的影响。

The Impact of the Use of Glycomacropeptide on Satiety and Dietary Intake in Phenylketonuria.

机构信息

Dietetic Department, Birmingham Children's Hospital, Steelhouse Lane, Birmingham B4 6NH, UK.

Liverpool Clinical Trials Centre, University of Liverpool, Brownlow Hill, Liverpool L69 3GL, UK.

出版信息

Nutrients. 2020 Sep 4;12(9):2704. doi: 10.3390/nu12092704.

DOI:10.3390/nu12092704
PMID:32899700
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7576483/
Abstract

UNLABELLED

Protein is the most satiating macronutrient, increasing secretion of gastrointestinal hormones and diet induced thermogenesis. In phenylketonuria (PKU), natural protein is restricted with approximately 80% of intake supplied by a synthetic protein source, which may alter satiety response. Casein glycomacropeptide (CGMP-AA), a carbohydrate containing peptide and alternative protein substitute to amino acids (AA), may enhance satiety mediated by its bioactive properties.

AIM

In a three-year longitudinal; prospective study, the effect of AA and two different amounts of CGMP-AA (CGMP-AA only (CGMP100) and a combination of CGMP-AA and AA (CGMP50) on satiety, weight and body mass index (BMI) were compared.

METHODS

48 children with PKU completed the study. Median ages of children were: CGMP100; ( = 13), 9.2 years; CGMP50; ( = 16), 7.3 years; and AA ( = 19), 11.1 years. Semi-quantitative dietary assessments and anthropometry (weight, height and BMI) were measured every three months.

RESULTS

The macronutrient contribution to total energy intake from protein, carbohydrate and fat was similar across the groups. Adjusting for age and gender, no differences in energy intake, weight, BMI, incidence of overweight or obesity was apparent between the groups.

CONCLUSION

In this three-year longitudinal study, there was no indication to support a relationship between CGMP and satiety, as evidenced by decreased energy intake, thereby preventing overweight or obesity. Satiety is a complex multi-system process that is not fully understood.

摘要

目的

在一项为期三年的前瞻性纵向研究中,比较了氨基酸(AA)和两种不同量的酪蛋白糖巨肽(CGMP-AA)(仅 CGMP-AA(CGMP100)和 CGMP-AA 与 AA 的组合(CGMP50)对饱腹感、体重和体重指数(BMI)的影响。

方法

48 名苯丙酮尿症(PKU)儿童完成了这项研究。儿童的中位数年龄为:CGMP100(n = 13),9.2 岁;CGMP50(n = 16),7.3 岁;AA(n = 19),11.1 岁。每三个月进行一次半定量膳食评估和人体测量(体重、身高和 BMI)。

结果

蛋白质、碳水化合物和脂肪在总能量摄入中的宏量营养素贡献在各组之间相似。调整年龄和性别后,各组之间的能量摄入、体重、BMI、超重或肥胖的发生率没有差异。

结论

在这项为期三年的纵向研究中,没有证据表明 CGMP 与饱腹感之间存在关系,因为能量摄入没有减少,从而防止了超重或肥胖。饱腹感是一个复杂的多系统过程,尚未完全理解。

相似文献

1
The Impact of the Use of Glycomacropeptide on Satiety and Dietary Intake in Phenylketonuria.甘氨酰酪氨酸对苯丙酮尿症患者饱腹感和饮食摄入的影响。
Nutrients. 2020 Sep 4;12(9):2704. doi: 10.3390/nu12092704.
2
Growth and Body Composition in PKU Children-A Three-Year Prospective Study Comparing the Effects of L-Amino Acid to Glycomacropeptide Protein Substitutes.苯丙酮尿症患儿的生长和身体成分:一项为期三年的前瞻性研究比较了 L-氨基酸和糖巨肽蛋白替代物的影响。
Nutrients. 2021 Apr 16;13(4):1323. doi: 10.3390/nu13041323.
3
A Three-Year Longitudinal Study Comparing Bone Mass, Density, and Geometry Measured by DXA, pQCT, and Bone Turnover Markers in Children with PKU Taking L-Amino Acid or Glycomacropeptide Protein Substitutes.一项为期三年的纵向研究比较了接受 L-氨基酸或糖巨肽蛋白替代物的 PKU 儿童的 DXA、pQCT 和骨转换标志物测量的骨量、密度和几何结构。
Nutrients. 2021 Jun 17;13(6):2075. doi: 10.3390/nu13062075.
4
The relationship between dietary intake, growth and body composition in Phenylketonuria.苯丙酮尿症患者的饮食摄入、生长和身体成分之间的关系。
Mol Genet Metab. 2017 Sep;122(1-2):36-42. doi: 10.1016/j.ymgme.2017.07.007. Epub 2017 Jul 20.
5
Glycomacropeptide: long-term use and impact on blood phenylalanine, growth and nutritional status in children with PKU.糖巨肽:在苯丙酮尿症患儿中的长期使用及其对血苯丙氨酸、生长和营养状况的影响。
Orphanet J Rare Dis. 2019 Feb 15;14(1):44. doi: 10.1186/s13023-019-1011-y.
6
Glycomacropeptide in children with phenylketonuria: does its phenylalanine content affect blood phenylalanine control?苯丙酮尿症患儿中的糖巨肽:其苯丙氨酸含量会影响血液苯丙氨酸的控制吗?
J Hum Nutr Diet. 2017 Aug;30(4):515-523. doi: 10.1111/jhn.12438. Epub 2017 Jan 22.
7
Preliminary Investigation to Review If a Glycomacropeptide Compared to L-Amino Acid Protein Substitute Alters the Pre- and Postprandial Amino Acid Profile in Children with Phenylketonuria.初步调查研究:甘氨酰酪氨酸肽对比 L-氨基酸蛋白替代物是否改变苯丙酮尿症患儿的餐前和餐后氨基酸谱。
Nutrients. 2020 Aug 14;12(8):2443. doi: 10.3390/nu12082443.
8
The Effect of Glycomacropeptide versus Amino Acids on Phenylalanine and Tyrosine Variability over 24 Hours in Children with PKU: A Randomized Controlled Trial.甘氨酰酪氨酸肽与氨基酸对苯丙氨酸和酪氨酸 24 小时变异性的影响:一项随机对照试验。
Nutrients. 2019 Feb 28;11(3):520. doi: 10.3390/nu11030520.
9
The effect of casein glycomacropeptide versus free synthetic amino acids for early treatment of phenylketonuria in a mice model.酪蛋白糖巨肽与游离合成氨基酸治疗苯丙酮尿症小鼠模型早期的效果比较。
PLoS One. 2022 Jan 11;17(1):e0261150. doi: 10.1371/journal.pone.0261150. eCollection 2022.
10
Casein Glycomacropeptide: An Alternative Protein Substitute in Tyrosinemia Type I.酪蛋白糖巨肽:I型酪氨酸血症中的一种替代蛋白质替代品。
Nutrients. 2021 Sep 16;13(9):3224. doi: 10.3390/nu13093224.

引用本文的文献

1
Nutritional profiling of foods for Phenylketonuria.苯丙酮尿症患者食物的营养成分分析
Sci Rep. 2025 Jul 2;15(1):22538. doi: 10.1038/s41598-025-06633-2.
2
Current Insights into Nutritional Management of Phenylketonuria: An Update for Children and Adolescents.苯丙酮尿症营养管理的最新见解:儿童和青少年最新情况
Children (Basel). 2025 Feb 7;12(2):199. doi: 10.3390/children12020199.
3
Morphofunctional Assessment beyond Malnutrition: Fat Mass Assessment in Adult Patients with Phenylketonuria-Systematic Review.肥胖症评估在苯丙酮尿症成年患者中的应用:系统综述
Nutrients. 2024 Jun 11;16(12):1833. doi: 10.3390/nu16121833.
4
Protein substitutions as new-generation pharmanutrition approach to managing phenylketonuria.蛋白质替代作为管理苯丙酮尿症的新一代药物营养方法。
Clin Exp Pediatr. 2023 Aug;66(8):320-331. doi: 10.3345/cep.2022.00584. Epub 2022 Nov 1.
5
Transitioning of protein substitutes in patients with phenylketonuria: evaluation of current practice.苯丙酮尿症患者蛋白质替代物的转换:现行实践评估。
Orphanet J Rare Dis. 2022 Oct 27;17(1):395. doi: 10.1186/s13023-022-02555-8.
6
Quality of life aspects of a low protein diet using GMP in patients with phenylketonuria.低蛋白饮食中使用 GMP 对苯丙酮尿症患者生活质量方面的影响。
J Int Med Res. 2022 Sep;50(9):3000605221125524. doi: 10.1177/03000605221125524.
7
Dietetic Management of Adults with Phenylketonuria (PKU) in the UK: A Care Consensus Document.英国成人苯丙酮尿症(PKU)患者的饮食管理:护理共识文件。
Nutrients. 2022 Jan 28;14(3):576. doi: 10.3390/nu14030576.
8
Effect of nutritional intervention on nutritional status among children with disorders of amino acid and nitrogen metabolism (AANMDs): A scoping review.营养干预对氨基酸和氮代谢紊乱(AANMDs)儿童营养状况的影响:一项范围综述。
Intractable Rare Dis Res. 2021 Nov;10(4):246-256. doi: 10.5582/irdr.2021.01124.
9
Unveiling the Metabolic Effects of Glycomacropeptide.揭示糖巨肽的代谢作用。
Int J Mol Sci. 2021 Sep 8;22(18):9731. doi: 10.3390/ijms22189731.
10
A Three-Year Longitudinal Study Comparing Bone Mass, Density, and Geometry Measured by DXA, pQCT, and Bone Turnover Markers in Children with PKU Taking L-Amino Acid or Glycomacropeptide Protein Substitutes.一项为期三年的纵向研究比较了接受 L-氨基酸或糖巨肽蛋白替代物的 PKU 儿童的 DXA、pQCT 和骨转换标志物测量的骨量、密度和几何结构。
Nutrients. 2021 Jun 17;13(6):2075. doi: 10.3390/nu13062075.

本文引用的文献

1
Preliminary Investigation to Review If a Glycomacropeptide Compared to L-Amino Acid Protein Substitute Alters the Pre- and Postprandial Amino Acid Profile in Children with Phenylketonuria.初步调查研究:甘氨酰酪氨酸肽对比 L-氨基酸蛋白替代物是否改变苯丙酮尿症患儿的餐前和餐后氨基酸谱。
Nutrients. 2020 Aug 14;12(8):2443. doi: 10.3390/nu12082443.
2
The effect of taste and taste perception on satiation/satiety: a review.味觉和味觉感知对饱腹感的影响:综述。
Food Funct. 2020 Apr 1;11(4):2838-2847. doi: 10.1039/c9fo02519g. Epub 2020 Mar 20.
3
Obesity Affects the Microbiota-Gut-Brain Axis and the Regulation Thereof by Endocannabinoids and Related Mediators.肥胖影响微生物群-肠道-大脑轴及其受内源性大麻素和相关介质的调节。
Int J Mol Sci. 2020 Feb 25;21(5):1554. doi: 10.3390/ijms21051554.
4
Acute effect of an amino acid mixture in the rat glycemic profile.氨基酸混合物对大鼠血糖谱的急性影响。
J Cell Biochem. 2019 Aug;120(8):13056-13065. doi: 10.1002/jcb.28576. Epub 2019 Mar 14.
5
Glycomacropeptide Bioactivity and Health: A Review Highlighting Action Mechanisms and Signaling Pathways.糖巨肽的生物活性与健康:一篇综述,重点介绍作用机制和信号通路。
Nutrients. 2019 Mar 12;11(3):598. doi: 10.3390/nu11030598.
6
Postprandial metabolic responses to ingestion of bovine glycomacropeptide compared to a whey protein isolate in prediabetic volunteers.进食牛糖巨肽与乳清蛋白分离物对糖尿病前期志愿者餐后代谢反应的比较。
Eur J Nutr. 2019 Aug;58(5):2067-2077. doi: 10.1007/s00394-018-1763-5. Epub 2018 Jul 12.
7
The complete European guidelines on phenylketonuria: diagnosis and treatment.《苯丙酮尿症的完整欧洲指南:诊断与治疗》。
Orphanet J Rare Dis. 2017 Oct 12;12(1):162. doi: 10.1186/s13023-017-0685-2.
8
Influence of diet on the gut microbiome and implications for human health.饮食对肠道微生物群的影响及其对人类健康的意义。
J Transl Med. 2017 Apr 8;15(1):73. doi: 10.1186/s12967-017-1175-y.
9
Glycomacropeptide Sustains Microbiota Diversity and Promotes Specific Taxa in an Artificial Colon Model of Elderly Gut Microbiota.在老年肠道微生物群的人工结肠模型中,糖巨肽可维持微生物群多样性并促进特定分类群。
J Agric Food Chem. 2017 Mar 1;65(8):1836-1846. doi: 10.1021/acs.jafc.6b05434. Epub 2017 Feb 17.
10
Glycomacropeptide in children with phenylketonuria: does its phenylalanine content affect blood phenylalanine control?苯丙酮尿症患儿中的糖巨肽:其苯丙氨酸含量会影响血液苯丙氨酸的控制吗?
J Hum Nutr Diet. 2017 Aug;30(4):515-523. doi: 10.1111/jhn.12438. Epub 2017 Jan 22.